quality-nonconformance

NCR lifecycle management requires identifying, containing, and dispositioning non-conformances, then escalating to MRB if necessary. This approach aligns with FDA QSR, IATF 16949, AS9100, and ISO 13485 regulatory standards for structured documentation.

Root cause analysis for a non-conformance involves structured methodologies like 5 Whys, Ishikawa, FTA, or 8D. Applying these techniques ensures evidence-based CAPA planning with verified effectiveness per regulatory requirements.

CAPA planning integrates with SCAR processes to manage supplier quality issues within AS9100 environments. It requires structured documentation, evidence-based corrective actions, and verification of effectiveness to maintain regulatory compliance.

Yes, supplier quality management covers ASL maintenance and TR/RTV workflows. These processes ensure non-conforming materials are controlled and suppliers meet quality requirements across FDA, IATF 16949, and ISO 13485 regulated manufacturing.

Escalate a non-conformance to the Material Review Board when standard disposition cannot resolve the quality issue. MRB escalation occurs after initial containment and identification steps within the NCR lifecycle fail to determine adequate corrective paths.

Audit readiness requires structured non-conformance documentation to prove regulatory compliance across ISO 13485 and AS9100. Evidence-based actions and verified CAPA effectiveness demonstrate that product safety and quality management system requirements are consistently met.